Home / The Disease

01 · The Disease

Hypertrophic cardiomyopathy, explained.

A common rare disease in which the heart muscle grows too thick, and the heart is left to work harder to do less.

PrevalenceAbout 1 in 500
FormsObstructive and non-obstructive
BasisOften inherited
OnsetAny age, often young adults

A heart that has to work harder to do less.

In hypertrophic cardiomyopathy, the muscular walls of the heart grow abnormally thick. That thickening stiffens the chamber, crowds the space available for blood, and interferes with the two things every heartbeat depends on: the ability to pump blood out to the body, and the ability to relax and fill with it in return.

The word itself describes the problem plainly. Hypertrophic means overgrown. Cardiomyopathy means disease of the heart muscle. Put together, they name a heart whose muscle has grown beyond what it needs, in a way that changes how the whole organ works.

HCM is, in a sense, a paradox. It is counted among the most common of the rare diseases, estimated to affect roughly one in 500 people in the United States. That makes it widespread enough to touch families in nearly every community, yet distinct enough that it has long gone underserved by therapies designed for its underlying biology.

Where the trouble begins

The thickening most often centres on the septum, the wall of muscle that divides the heart's two lower chambers. As that wall grows, it narrows the left ventricle, the heart's main pumping chamber, and stiffens the muscle so that it no longer relaxes easily between beats. A stiff chamber fills poorly, and a crowded chamber holds less. The heart responds the only way it can, by working harder.

There is a second, subtler problem. As the muscle thickens, it can also begin to contract too forcefully, an excess of the very force a heart is built to produce. This overactivity sits at the centre of the disease, and it is the part of the story our science is designed to address.

Normal heart wall compared with a thickened wall in HCM Two cross-sections of the heart's left ventricle. On the left, a normal wall surrounds an open chamber. On the right, the wall is thickened and the chamber is narrowed. wall NORMAL thickened HCM
Fig. 02 · Left-ventricular wall, schematic Healthy muscle  Thickened muscle
≈1 in 500
Estimated prevalence in the United States, among the most common of the rare diseases
2 forms
Obstructive and non-obstructive HCM, both addressed by EYEAM's programme
50 percent
Roughly the share of cases with a family history, reflecting its inherited basis

Symptoms

How it can feel.

The mechanics of a thickened, overworking heart translate into a cluster of symptoms that quietly narrows the boundaries of an ordinary day.

Shortness of breath

Breathlessness on exertion, and sometimes at rest, as the stiffened heart struggles to keep pace with the body's demand for blood.

Chest pain

Pressure or pain in the chest, often with activity, as the thickened muscle demands more oxygen than it readily receives.

Fatigue

A persistent, low-running tiredness, the cumulative cost of a heart that has to work harder for every beat it takes.

Fainting

Light-headedness or a sudden loss of consciousness, especially during exertion, a sign that can carry serious risk.

Symptoms vary widely from person to person. Some people with HCM live for years without noticing anything at all, while others feel its effects daily. That variability is one of the reasons the disease can go unrecognised, and one of the reasons careful, individual assessment matters so much.

Two forms

Two forms of the disease, one underlying mechanism.

Clinicians distinguish HCM by whether the thickened muscle physically blocks the flow of blood out of the heart. Both forms share the same overactive muscle at their root, which is why a mechanism-directed medicine has reason to matter in each.

Obstructive HCM

The path out is narrowed.

In obstructive HCM, the thickened muscle narrows the channel that blood travels as it leaves the heart. Outflow is obstructed, and the heart must generate still more force to push blood past the blockage, compounding the burden the disease already places on it. This is the more commonly recognised form, and the obstruction can often be measured directly.

Non-obstructive HCM

The muscle is thick, but the path is clear.

In non-obstructive HCM, the muscle is thickened and stiff but does not block outflow in the same way. The obstruction may be absent, yet the abnormal mechanics of the muscle, and the symptoms they produce, remain very much present. Historically this form has had fewer options directed at its underlying biology.

Where it comes from, and who it reaches.

For many people, HCM is inherited. It is frequently caused by changes in the genes that build the sarcomere, the microscopic contractile unit that generates each heartbeat. When those genes carry certain variants, the muscle they build can grow and behave abnormally over time. Because the condition often runs in families, a diagnosis in one person can be reason for relatives to be evaluated as well.

HCM does not respect a single profile. It affects people of every age, background and level of fitness. It is recognised as one of the more common causes of sudden cardiac events in young people, including athletes, which is part of why timely recognition carries such weight. For most people, however, HCM is a chronic condition to be understood and managed over many years.

How it is found

HCM is often first suspected from a heart murmur, an abnormal reading on an electrocardiogram, or symptoms during exertion. It is most clearly seen on an echocardiogram, an ultrasound of the heart that lets clinicians measure the thickness of the muscle and watch how the chambers fill and empty. Cardiac magnetic resonance imaging can add further detail, and genetic testing can clarify the inherited picture for a person and their family.

Diagnosis is only the beginning. Because the disease presents so differently from one person to the next, care is tailored to the individual, weighing symptoms, the form of the disease, the risk of serious events, and the person's own goals for daily life.

Next

From the disease to the medicine.

If HCM is a disease of overactive heart muscle, the natural question is how a therapy can reach that overactivity at its source. That is where our science begins.